ea0056p523 | Endocrine Disruptors | ECE2018
Donat-Vargas Carolina
, Bergdahl Ingvar A.
, Tornevi Andreas
, Wennberg Maria
, Sommar Johan
, Kiviranta Hannu
, Rantakokko Panu
, Rolandsson Olov
, AEkesson Agneta
Background: Perfluoroalkyl Substances (PFAS) have drawn much attention due to environment bioaccumulation potential and their presence worldwide in human blood. Exposure to PFAS is suspected to induce endocrine-disrupting hormonal effects and may be involved in the development of type 2 diabetes (T2D). However, epidemiological evidence is scarce and inconsistent.Objective: We aimed to investigate the association of PFAS plasma levels on the risk of devel...